EVERYMAN MEDIA GROUP (EMAN) H2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 TU earnings summary
27 Jan, 2026Executive summary
Admissions increased 2.3% year-over-year to 4.4 million, reflecting steady audience growth.
Revenue rose 8.7% to £116.5m compared to the previous year, with EBITDA up 4.9% to £17.0m.
Market share expanded by 40 basis points to 5.8%, supported by new venue openings and enhanced customer experience.
Financial highlights
Group revenue reached £116.5m, up from £107.2m in FY24 (8.7% increase).
EBITDA grew to £17.0m from £16.2m, a 4.9% rise year-over-year.
Food and beverage spend per head increased 6.4% to £11.32.
Paid for average ticket price rose 4.4% to £12.51.
Net debt increased to £22.0m from £18.1m.
Outlook and guidance
FY25 performance aligned with previous guidance provided in December 2025.
No new venues planned for 2026 as part of a strategy to reduce net debt.
Further strategic details to be shared with full year results in April 2026.
Latest events from EVERYMAN MEDIA GROUP
- Revenue up 18% and market share rose, but higher costs led to a larger net loss.EMAN
H2 202419 Feb 2026 - FY25 revenue and EBITDA will rise but miss forecasts amid a softer UK box office.EMAN
Trading Update10 Dec 2025 - Double-digit growth in revenue and EBITDA, with expanding membership and reduced net debt.EMAN
H1 202524 Sep 2025 - Revenue up 17.9%, membership up 65%, and new venues planned despite market headwinds.EMAN
Trading Update6 Jun 2025 - Record July admissions and strong H2 film slate support confidence in meeting 2023 targets.EMAN
Trading Update5 Jun 2025 - Double-digit growth and venue expansion position Everyman for a strong 2024.EMAN
Trading Update5 Jun 2025 - H1 2023 saw resilient trading and margin gains, with strong outlook supported by new venues.EMAN
H1 20235 Jun 2025 - H1 growth in revenue and admissions sets up Everyman for a strong, expectation-beating year.EMAN
Trading Update5 Jun 2025 - Revenue, admissions, and market share surged, with strong H2 and full-year outlook expected.EMAN
H1 20245 Jun 2025